- Home
- EVOK vs CDIO Comparison
EVOK vs CDIO Comparison
Compare EVOK & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- CDIO
- Stock Information
- Founded
- EVOK 2007
- CDIO 2017
- Country
- EVOK United States
- CDIO United States
- Employees
- EVOK N/A
- CDIO N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- EVOK Health Care
- CDIO Health Care
- Exchange
- EVOK Nasdaq
- CDIO Nasdaq
- Market Cap
- EVOK 7.6M
- CDIO 8.0M
- IPO Year
- EVOK 2013
- CDIO N/A
- Fundamental
- Price
- EVOK $5.15
- CDIO $4.04
- Analyst Decision
- EVOK
- CDIO
- Analyst Count
- EVOK 0
- CDIO 0
- Target Price
- EVOK N/A
- CDIO N/A
- AVG Volume (30 Days)
- EVOK 26.0K
- CDIO 38.8K
- Earning Date
- EVOK 11-07-2025
- CDIO 11-14-2025
- Dividend Yield
- EVOK N/A
- CDIO N/A
- EPS Growth
- EVOK N/A
- CDIO N/A
- EPS
- EVOK N/A
- CDIO N/A
- Revenue
- EVOK $12,794,859.00
- CDIO $19,507.00
- Revenue This Year
- EVOK $57.38
- CDIO $1,434.82
- Revenue Next Year
- EVOK $59.57
- CDIO $4,661.91
- P/E Ratio
- EVOK N/A
- CDIO N/A
- Revenue Growth
- EVOK 70.02
- CDIO N/A
- 52 Week Low
- EVOK $1.94
- CDIO $3.22
- 52 Week High
- EVOK $9.88
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- EVOK 57.04
- CDIO 46.94
- Support Level
- EVOK $4.53
- CDIO $4.00
- Resistance Level
- EVOK $5.19
- CDIO $4.54
- Average True Range (ATR)
- EVOK 0.28
- CDIO 0.33
- MACD
- EVOK 0.07
- CDIO -0.04
- Stochastic Oscillator
- EVOK 91.26
- CDIO 23.46
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.